Advance Patient Choice
DPC promotes preserving and expanding patients’ autonomy where alternative options are or should be available, including choice of treatment modalities, choice of providers, choice of health plans, and access to transplantation; as well as protections for donor and recipient patients.
Related Information
Dialysis Patient Citizens Announces First-in-the-Nation Kidney Disease Training Curriculum for Community Health Workers
Registration is now open for community health workers to sign up for the CHW Chronic Kidney Disease Training through the Illinois Public Health Association WASHINGTON, D.C. (July 11, 2024) - Today, Dialysis Patient Citizens [...]
DPC Asks Medicare Officials to Reverse Pruritis Drug Fiasco
In a letter to the Center for Medicare and Medicaid Services (CMS), Dialysis Patient Citizens (DPC) asked for a “do-over” in the rollout of Korsuva, a drug that treats ESRD-related pruritis. Medicare makes an add-on [...]
DPC’s Letter to Hon. Jonathan Blum, Principal Deputy Administrator for CMS, on New Drugs in the ESRD PPS
June 11, 2024 The Honorable Jonathan Blum Principal Deputy Administrator Centers for Medicare & Medicaid Services 200 Independence Avenue, SW Washington, DC 20515 Re: New drugs in the ESRD PPS Dear Principal Deputy Administrator [...]
DPC’s 2024 Advocacy Day
Earlier this month, DPC hosted our annual Advocacy Day in Washington, D.C. where we bring together patients, family members, and care givers to meet with their Members of Congress to elevate the patient story [...]
DPC Seeks Information on Patients’ Experience With Itching
A couple of years ago, a new drug was approved to treat ESRD-related pruritis. Medicare approved an additional payment for the drug Korsuva for a period of 2 years. But, because of the short expiration [...]
DPC Celebrates 20th Anniversary
Since our founding 20 years ago, Dialysis Patient Citizens (DPC) has had the privilege of working with amazing advocates to help elevate the patient voice with policy makers to improve their quality of life. At [...]
